Opportunity Information: Apply for CDC RFA IP13 1304
Apply for CDC RFA IP13 1304
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic Influenza by National Health Authorities outside the United States" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Feb 27, 2013 and posted on Feb 27, 2013.
- Applicants must submit their applications by Apr 29, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $12,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- The number of recipients for this funding is limited to 7 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Only the following foreign governments (who are completing four year agreements under the announcement IP09 902) may submit applications through their Ministries of Health or other national Government offices responsible for maintaining influenza surveillance systems for human disease Egypt, Madagascar, Moldova, Nepal, Paraguay, Sri Lanka and Zambia. The intention of this new announcement, Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic Influenza by National Health Authorities outside the United States, is to develop sustainable international capacity to prepare for, detect, and respond to an influenza pandemic and to monitor changes in seasonal influenza viruses. This RFA is limited to selected foreign governments based upon their completion of a preceding four year cooperative agreement with CDC for the development of influenza surveillance. The goal of this new award is to allow countries time to develop written and concrete plans and methods to sustain the surveillance systems set up under the first cooperative agreement or program. Plans must include phasing out U.S. Government financial assistance and transitioning to on going national government support for the routine influenza surveillance networks beyond this five year agreement. By increasing preparedness and response capabilities around the world with the intent of stopping, slowing or otherwise limiting the spread of a pandemic, the U.S. and countries around the globe will be in a better position to protect the health of their citizens. )
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic Influenza by National Health Authorities outside the United States" (CDC RFA IP13-1304), is a CDC cooperative agreement designed to help a small set of countries move from externally supported influenza surveillance toward fully self-sustained national systems. It builds directly on earlier CDC support provided under a prior four-year cooperative agreement (IP09-902), with the main goal of protecting and preserving the surveillance networks and laboratory capacities that were created or strengthened during that earlier funding period. The program is framed around long-term public health security: improving each country s ability to detect influenza threats quickly, respond effectively, and track seasonal influenza trends so decision-makers can understand burden and impact.
Eligibility is limited and very specific. Only the foreign governments of Egypt, Madagascar, Moldova, Nepal, Paraguay, Sri Lanka, and Zambia may apply, and they must do so through their Ministries of Health or other national government offices responsible for human influenza surveillance. The restriction reflects the intent of the award: it is not a general open competition, but a continuation pathway for countries that already completed the earlier CDC-supported surveillance development effort. The expectation is that these national authorities already have some established surveillance and laboratory foundation, and the new funding period is meant to help them formalize, institutionalize, and financially transition those systems into routine government operations.
The central purpose is sustainability. Countries are expected to develop and implement detailed, concrete plans to assume full responsibility and funding for routine influenza surveillance, including systems that can handle seasonal influenza as well as novel or pandemic strains. The surveillance approach is meant to be both robust and timely, meaning it should reliably gather data on an ongoing basis and also be capable of rapidly escalating during unusual events. While countries are encouraged to strengthen surveillance for severe respiratory disease (often a high-value strategy because it focuses on hospitalized or severe cases that can signal serious outbreaks), the opportunity does not force a single model and allows flexibility in how countries structure their surveillance networks as long as they meet core performance expectations.
A major technical requirement is continued alignment with the World Health Organization s global influenza architecture. Countries receiving funding must maintain, or demonstrably make progress toward, an active WHO National Influenza Center (NIC) laboratory. They are also expected to contribute regularly to the WHO Global Influenza Surveillance and Response System (GISRS). In practical terms, this means the funded countries should be generating and sharing virologic and epidemiologic information in a way that strengthens global situational awareness, supports influenza strain monitoring, and contributes to broader pandemic preparedness. The emphasis on NIC status and GISRS participation signals that the CDC is not only investing in country-level capacity, but also in the reliability of data and virus sharing needed for regional and global risk assessment.
The award structure is a cooperative agreement, which typically means the CDC anticipates substantial involvement beyond simply providing funds, such as technical collaboration, guidance, and coordination on surveillance standards, laboratory systems, reporting, and preparedness planning. Financially, the opportunity anticipated seven awards total, matching the seven eligible countries. The estimated total funding amount is $12.5 million across the program, with an award ceiling of $500,000 and an award floor of $100,000. There is no cost sharing or matching requirement stated. The funding activity category is health, and the CFDA number referenced is 93.283 (CDC Investigations and Technical Assistance).
One of the most defining features of the opportunity is the planned transition away from US government financing. Each funded country is required to develop and implement a five-year phase-out plan for US financial assistance to its influenza surveillance system. The program is explicit that the endpoint should be ongoing national government support beyond the five-year cooperative agreement. In other words, the grant is intended to buy time and provide structured support while countries shift budgeting, staffing, procurement, and operating costs into domestic funding streams. At the same time, the CDC notes that the end of financial assistance does not necessarily end collaboration: the countries could still engage in future technical work with the CDC after the agreement ends, and they may remain eligible for other US government funding opportunities related to influenza, such as research or policy-oriented work in prevention and control.
From a public health impact standpoint, the opportunity is positioned as part of a broader preparedness strategy: if more countries can rapidly detect and contain emerging influenza threats, the likelihood of stopping, slowing, or limiting pandemic spread improves, benefiting both the funded countries and the wider international community. The operational vision is a mature surveillance system that routinely monitors influenza trends, quickly identifies unusual patterns or novel viruses, feeds data into national decision-making, and contributes to global surveillance channels through a functional NIC and steady GISRS reporting. The announcement was posted February 27, 2013, and had an original and final closing date of April 29, 2013, with archiving on May 29, 2013.
For administrative help accessing the full announcement, the contact listed is the CDC Procurement and Grants Office Technical Information Management Section (TIMS), with phone number 770-488-2700 and email pgotim@cdc.gov.
Frequently Asked Questions (FAQs)
What is the title and identifier of this grant opportunity?
The opportunity is titled "Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic Influenza by National Health Authorities outside the United States" and is identified as CDC RFA IP13-1304.
What type of funding mechanism is this?
This is a CDC cooperative agreement. A cooperative agreement typically indicates substantial CDC involvement beyond funding alone, such as technical collaboration, guidance, coordination, and support on surveillance standards, laboratory systems, reporting, and preparedness planning.
What is the main purpose of the program?
The central purpose is sustainability: helping countries transition from externally supported influenza surveillance to fully self-sustained national systems. The program aims to protect and preserve surveillance networks and laboratory capacities that were created or strengthened under earlier CDC support.
How does this opportunity relate to prior CDC funding?
This program builds directly on earlier CDC support provided under a prior four-year cooperative agreement (IP09-902). It is intended as a continuation pathway to maintain and institutionalize the surveillance and laboratory foundations established during that earlier period.
Who is eligible to apply?
Eligibility is limited to the foreign governments of Egypt, Madagascar, Moldova, Nepal, Paraguay, Sri Lanka, and Zambia, applying through their Ministries of Health or other national government offices responsible for human influenza surveillance.
Is this an open competition for any country or organization?
No. The eligibility restriction reflects the intent of the award: it is not a general open competition. It is specifically designed for a small set of countries that already completed earlier CDC-supported surveillance development work.
How many awards were anticipated?
Seven awards were anticipated in total, corresponding to the seven eligible countries.
How much funding is available under this program?
The estimated total funding amount is $12.5 million across the program.
What are the minimum and maximum award amounts?
The award floor is $100,000 and the award ceiling is $500,000.
Is cost sharing or matching required?
No cost sharing or matching requirement is stated for this opportunity.
What is the CFDA number for this funding?
The CFDA number referenced is 93.283 (CDC Investigations and Technical Assistance).
What is the overall public health goal of the funded work?
The program is framed around long-term public health security: improving each country s ability to detect influenza threats quickly, respond effectively, and track seasonal influenza trends so decision-makers can understand burden and impact.
What does "sustainability" mean in the context of this grant?
Sustainability here means developing and implementing detailed, concrete plans for the national government to assume full responsibility and funding for routine influenza surveillance, including the systems needed for seasonal influenza and novel or pandemic strains.
Are countries required to transition away from US government financing?
Yes. Each funded country is required to develop and implement a five-year phase-out plan for US financial assistance to its influenza surveillance system, with the endpoint being ongoing national government support beyond the five-year cooperative agreement.
Does the end of funding mean the end of collaboration with CDC?
Not necessarily. The CDC notes that the end of financial assistance does not necessarily end collaboration, and countries could still engage in future technical work with CDC after the agreement ends.
Can countries remain eligible for other US government influenza-related funding after this agreement?
Yes. The opportunity notes that countries may remain eligible for other US government funding opportunities related to influenza, such as research or policy-oriented work in prevention and control.
What kind of surveillance systems are countries expected to support?
Countries are expected to support robust and timely influenza surveillance systems that reliably gather ongoing data and can rapidly escalate during unusual events, including novel or pandemic strains.
Is there a required surveillance model that countries must follow?
No single model is mandated. While strengthening surveillance for severe respiratory disease is encouraged, the opportunity allows flexibility in how countries structure their surveillance networks as long as they meet core performance expectations.
Why is severe respiratory disease surveillance highlighted?
It is described as a high-value strategy because it focuses on hospitalized or severe cases that can signal serious outbreaks, supporting early detection and response.
What are the key World Health Organization (WHO) expectations for funded countries?
Funded countries must maintain, or demonstrably make progress toward, an active WHO National Influenza Center (NIC) laboratory and are expected to contribute regularly to the WHO Global Influenza Surveillance and Response System (GISRS).
What does contributing to GISRS mean in practical terms?
It means generating and sharing virologic and epidemiologic information in a way that strengthens global situational awareness, supports influenza strain monitoring, and contributes to broader pandemic preparedness.
Why does the opportunity emphasize NIC status and GISRS participation?
The emphasis signals that CDC is investing not only in country-level capacity, but also in reliable data and virus sharing needed for regional and global risk assessment.
What is the funding activity category?
The funding activity category is health.
When was the announcement posted and when did it close?
The announcement was posted on February 27, 2013. The original and final closing date was April 29, 2013. The opportunity was archived on May 29, 2013.
Who can be contacted for administrative help accessing the full announcement?
The contact listed is the CDC Procurement and Grants Office Technical Information Management Section (TIMS). Phone: 770-488-2700. Email: pgotim@cdc.gov.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Service Area Competition Additional Area (SAC AA) Baxley, GA and Brooklyn, NY
Previous opportunity: Early Career Projects Science for Sustainable and Healthy Tribes Indoor Air Impacts
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA IP13 1304
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA IP13 1304) also looked into and applied for these:
| Funding Opportunity |
|---|
| Service Area Competition Additional Area (SAC AA) Baxley, GA and Brooklyn, NY Apply for HRSA 13 271 Funding Number: HRSA 13 271 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Support and Implement Behavioral Change Communication to Increase Uptake of Highly Effective Prevention Services and Behaviors in Selected Urban and Rural Populations in the Southern and Western Provinces of the Republic of Zambia under the President Apply for CDC RFA GH13 1351 Funding Number: CDC RFA GH13 1351 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| NINDS Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows in MD PhD Programs (F31) Apply for PAR 13 127 Funding Number: PAR 13 127 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Increase Access to Comprehensive HIV/AIDS Prevention Care and Treatment Services in the Democratic Republic of Congo under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1321 Funding Number: CDC RFA GH13 1321 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $12,000,000 |
| Provision of Comprehensive Care and Treatment Programs by Local Indigenous Entities in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1322 Funding Number: CDC RFA GH13 1322 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $10,000,000 |
| Strengthening Human Resources for Health through Public Health Training Improvements at the Muhimbili University of Health and Allied Sciences (MUHAS), School of Public Health and Social Sciences (SPHSS) in the United Republic of Tanzania under PEPFA Apply for CDC RFA GH13 1323 Funding Number: CDC RFA GH13 1323 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Technical Assistance for Strengthening of Blood Transfusion Services and Increasing Access to Safe Blood in India under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1360 Funding Number: CDC RFA GH13 1360 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Supporting the implementation and capacity building of HIV/AIDS prevention interventions for youth using evidence based approaches in South Africa under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1341 Funding Number: CDC RFA GH13 1341 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $6,000,000 |
| Accelerating Progress Against TB in Kenya (APA K) Apply for RFA 615 13 000003 Funding Number: RFA 615 13 000003 Agency: Kenya USAID Nairobi Category: Health Funding Amount: $40,000,000 |
| Genomes to Natural Products (U01) Apply for RFA GM 14 002 Funding Number: RFA GM 14 002 Agency: National Institutes of Health Category: Health Funding Amount: $2,250,000 |
| Investigator Initiated Multi Site Clinical Trials (Collaborative R01) Apply for PAR 13 128 Funding Number: PAR 13 128 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alzheimers Disease Research Centers (P50) Apply for RFA AG 13 019 Funding Number: RFA AG 13 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43) Apply for RFA AR 14 005 Funding Number: RFA AR 14 005 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Collaborations for Macromolecular Interactions in Cells (R01) Apply for RFA GM 14 004 Funding Number: RFA GM 14 004 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Research Networks for Macromolecular Interactions in Cells (U54) Apply for RFA GM 14 005 Funding Number: RFA GM 14 005 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIH Directors Biomedical Research Workforce Innovation Award Broadening Experiences in Scientific Training (BEST) (DP7) Apply for RFA RM 12 022 Funding Number: RFA RM 12 022 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| NGO Health Service Delivery Program Apply for RFA 442 13 000001 Funding Number: RFA 442 13 000001 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $6,600,000 |
| Advancing Eating Disorders Research through Dimensional Studies of Biology and Behavior (R01) Apply for RFA MH 14 030 Funding Number: RFA MH 14 030 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Program for Extramural/Intramural Alcohol Research Collaborations (U01) Apply for PAR 13 133 Funding Number: PAR 13 133 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| HIV Prevention with Key Populations Mali Apply for RFA 688 13 000004 Funding Number: RFA 688 13 000004 Agency: Mali USAID Bamako Category: Health Funding Amount: $2,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA IP13 1304", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.